The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Synopsis
The global Erdosteine market was valued at US$ 79 million in 2023 and is anticipated to reach US$ 109.2 million by 2030, witnessing a CAGR of 4.4% during the forecast period 2024-2030.
North American market for Erdosteine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Erdosteine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Erdosteine include Edmond Pharma, Alitair Pharmaceuticals, Zhejiang Kangle Pharmaceutical, Wuhan Yuancheng Pharmaceutical and Shanghai Pukang Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Erdosteine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Erdosteine.
Report Scope
The Erdosteine market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Erdosteine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Erdosteine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Edmond Pharma
Alitair Pharmaceuticals
Zhejiang Kangle Pharmaceutical
Wuhan Yuancheng Pharmaceutical
Shanghai Pukang Pharmaceuticals
Segment by Type
Tablets
Capsules
Segment by Application
Bronchitis
Nasopharyngitis
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Erdosteine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Erdosteine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Erdosteine market was valued at US$ 79 million in 2023 and is anticipated to reach US$ 109.2 million by 2030, witnessing a CAGR of 4.4% during the forecast period 2024-2030.
North American market for Erdosteine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Erdosteine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Erdosteine include Edmond Pharma, Alitair Pharmaceuticals, Zhejiang Kangle Pharmaceutical, Wuhan Yuancheng Pharmaceutical and Shanghai Pukang Pharmaceuticals, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Erdosteine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Erdosteine.
Report Scope
The Erdosteine market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Erdosteine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Erdosteine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Edmond Pharma
Alitair Pharmaceuticals
Zhejiang Kangle Pharmaceutical
Wuhan Yuancheng Pharmaceutical
Shanghai Pukang Pharmaceuticals
Segment by Type
Tablets
Capsules
Segment by Application
Bronchitis
Nasopharyngitis
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Erdosteine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Erdosteine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Erdosteine Market Overview
1.1 Product Overview and Scope of Erdosteine
1.2 Erdosteine Segment by Type
1.2.1 Global Erdosteine Market Value Comparison by Type (2024-2030)
1.2.2 Tablets
1.2.3 Capsules
1.3 Erdosteine Segment by Application
1.3.1 Global Erdosteine Market Value by Application: (2024-2030)
1.3.2 Bronchitis
1.3.3 Nasopharyngitis
1.3.4 Others
1.4 Global Erdosteine Market Size Estimates and Forecasts
1.4.1 Global Erdosteine Revenue 2019-2030
1.4.2 Global Erdosteine Sales 2019-2030
1.4.3 Global Erdosteine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Erdosteine Market Competition by Manufacturers
2.1 Global Erdosteine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Erdosteine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Erdosteine Average Price by Manufacturers (2019-2024)
2.4 Global Erdosteine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Erdosteine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Erdosteine, Product Type & Application
2.7 Erdosteine Market Competitive Situation and Trends
2.7.1 Erdosteine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Erdosteine Players Market Share by Revenue
2.7.3 Global Erdosteine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Erdosteine Retrospective Market Scenario by Region
3.1 Global Erdosteine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Erdosteine Global Erdosteine Sales by Region: 2019-2030
3.2.1 Global Erdosteine Sales by Region: 2019-2024
3.2.2 Global Erdosteine Sales by Region: 2025-2030
3.3 Global Erdosteine Global Erdosteine Revenue by Region: 2019-2030
3.3.1 Global Erdosteine Revenue by Region: 2019-2024
3.3.2 Global Erdosteine Revenue by Region: 2025-2030
3.4 North America Erdosteine Market Facts & Figures by Country
3.4.1 North America Erdosteine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Erdosteine Sales by Country (2019-2030)
3.4.3 North America Erdosteine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Erdosteine Market Facts & Figures by Country
3.5.1 Europe Erdosteine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Erdosteine Sales by Country (2019-2030)
3.5.3 Europe Erdosteine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Erdosteine Market Facts & Figures by Country
3.6.1 Asia Pacific Erdosteine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Erdosteine Sales by Country (2019-2030)
3.6.3 Asia Pacific Erdosteine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Erdosteine Market Facts & Figures by Country
3.7.1 Latin America Erdosteine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Erdosteine Sales by Country (2019-2030)
3.7.3 Latin America Erdosteine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Erdosteine Market Facts & Figures by Country
3.8.1 Middle East and Africa Erdosteine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Erdosteine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Erdosteine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Erdosteine Sales by Type (2019-2030)
4.1.1 Global Erdosteine Sales by Type (2019-2024)
4.1.2 Global Erdosteine Sales by Type (2025-2030)
4.1.3 Global Erdosteine Sales Market Share by Type (2019-2030)
4.2 Global Erdosteine Revenue by Type (2019-2030)
4.2.1 Global Erdosteine Revenue by Type (2019-2024)
4.2.2 Global Erdosteine Revenue by Type (2025-2030)
4.2.3 Global Erdosteine Revenue Market Share by Type (2019-2030)
4.3 Global Erdosteine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Erdosteine Sales by Application (2019-2030)
5.1.1 Global Erdosteine Sales by Application (2019-2024)
5.1.2 Global Erdosteine Sales by Application (2025-2030)
5.1.3 Global Erdosteine Sales Market Share by Application (2019-2030)
5.2 Global Erdosteine Revenue by Application (2019-2030)
5.2.1 Global Erdosteine Revenue by Application (2019-2024)
5.2.2 Global Erdosteine Revenue by Application (2025-2030)
5.2.3 Global Erdosteine Revenue Market Share by Application (2019-2030)
5.3 Global Erdosteine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Edmond Pharma
6.1.1 Edmond Pharma Corporation Information
6.1.2 Edmond Pharma Description and Business Overview
6.1.3 Edmond Pharma Erdosteine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Edmond Pharma Erdosteine Product Portfolio
6.1.5 Edmond Pharma Recent Developments/Updates
6.2 Alitair Pharmaceuticals
6.2.1 Alitair Pharmaceuticals Corporation Information
6.2.2 Alitair Pharmaceuticals Description and Business Overview
6.2.3 Alitair Pharmaceuticals Erdosteine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Alitair Pharmaceuticals Erdosteine Product Portfolio
6.2.5 Alitair Pharmaceuticals Recent Developments/Updates
6.3 Zhejiang Kangle Pharmaceutical
6.3.1 Zhejiang Kangle Pharmaceutical Corporation Information
6.3.2 Zhejiang Kangle Pharmaceutical Description and Business Overview
6.3.3 Zhejiang Kangle Pharmaceutical Erdosteine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Zhejiang Kangle Pharmaceutical Erdosteine Product Portfolio
6.3.5 Zhejiang Kangle Pharmaceutical Recent Developments/Updates
6.4 Wuhan Yuancheng Pharmaceutical
6.4.1 Wuhan Yuancheng Pharmaceutical Corporation Information
6.4.2 Wuhan Yuancheng Pharmaceutical Description and Business Overview
6.4.3 Wuhan Yuancheng Pharmaceutical Erdosteine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Wuhan Yuancheng Pharmaceutical Erdosteine Product Portfolio
6.4.5 Wuhan Yuancheng Pharmaceutical Recent Developments/Updates
6.5 Shanghai Pukang Pharmaceuticals
6.5.1 Shanghai Pukang Pharmaceuticals Corporation Information
6.5.2 Shanghai Pukang Pharmaceuticals Description and Business Overview
6.5.3 Shanghai Pukang Pharmaceuticals Erdosteine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Shanghai Pukang Pharmaceuticals Erdosteine Product Portfolio
6.5.5 Shanghai Pukang Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Erdosteine Industry Chain Analysis
7.2 Erdosteine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Erdosteine Production Mode & Process
7.4 Erdosteine Sales and Marketing
7.4.1 Erdosteine Sales Channels
7.4.2 Erdosteine Distributors
7.5 Erdosteine Customers
8 Erdosteine Market Dynamics
8.1 Erdosteine Industry Trends
8.2 Erdosteine Market Drivers
8.3 Erdosteine Market Challenges
8.4 Erdosteine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
